Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?

Black, LE Green, JD Rener, J Dayan, A Cavagnaro, JA Spindler, P Bussiere, JL Bouchard, P Inoue, T Thomas, PT Essayan, DM Gillett, NA Hart, TK Hastings, K House, RV Latta, D Liminga, U Treacy, G Wierda, D

Le. Black et al., Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?, HUM EXP TOX, 19(4), 2000, pp. 205-206

Pharmacology & Toxicology

HUMAN & EXPERIMENTAL TOXICOLOGY

09603271 → ACNP

19

4

2000

205 - 206

ISI

0960-3271(200004)19:4<205:SEOIBC>2.0.ZU;2-W